Literature DB >> 23529623

Importance of PdpC, IglC, IglI, and IglG for modulation of a host cell death pathway induced by Francisella tularensis.

Marie Lindgren1, Kjell Eneslätt, Jeanette E Bröms, Anders Sjöstedt.   

Abstract

Modulation of host cell death pathways appears to be a prerequisite for the successful lifestyles of many intracellular pathogens. The facultative intracellular bacterium Francisella tularensis is highly pathogenic, and effective proliferation in the macrophage cytosol leading to host cell death is a requirement for its virulence. To better understand the prerequisites of this cell death, macrophages were infected with the F. tularensis live vaccine strain (LVS), and the effects were compared to those resulting from infections with deletion mutants lacking expression of either of the pdpC, iglC, iglG, or iglI genes, which encode components of the Francisella pathogenicity island (FPI), a type VI secretion system. Within 12 h, a majority of the J774 cells infected with the LVS strain showed production of mitochondrial superoxide and, after 24 h, marked signs of mitochondrial damage, caspase-9 and caspase-3 activation, phosphatidylserine expression, nucleosome formation, and membrane leakage. In contrast, neither of these events occurred after infection with the ΔiglI or ΔiglC mutants, although the former strain replicated. The ΔiglG mutant replicated effectively but induced only marginal cytopathogenic effects after 24 h and intermediate effects after 48 h. In contrast, the ΔpdpC mutant showed no replication but induced marked mitochondrial superoxide production and mitochondrial damage, caspase-3 activation, nucleosome formation, and phosphatidylserine expression, although the effects were delayed compared to those obtained with LVS. The unique phenotypes of the mutants provide insights regarding the roles of individual FPI components for the modulation of the cytopathogenic effects resulting from the F. tularensis infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529623      PMCID: PMC3676040          DOI: 10.1128/IAI.00275-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence.

Authors:  Tyler K Ulland; Blake W Buchan; Margaret R Ketterer; Teresa Fernandes-Alnemri; David K Meyerholz; Michael A Apicella; Emad S Alnemri; Bradley D Jones; William M Nauseef; Fayyaz S Sutterwala
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

Review 2.  Tularemia vaccines: recent developments and remaining hurdles.

Authors:  J Wayne Conlan
Journal:  Future Microbiol       Date:  2011-04       Impact factor: 3.165

3.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

4.  Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages.

Authors:  Xin-He Lai; Anders Sjöstedt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  A Francisella tularensis pathogenicity island required for intramacrophage growth.

Authors:  Francis E Nano; Na Zhang; Siobhán C Cowley; Karl E Klose; Karen K M Cheung; Michael J Roberts; Jagjit S Ludu; Gregg W Letendre; Anda I Meierovics; Gwen Stephens; Karen L Elkins
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

Review 6.  Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors.

Authors:  Thomas Henry; Denise M Monack
Journal:  Cell Microbiol       Date:  2007-07-27       Impact factor: 3.715

7.  A conserved alpha-helix essential for a type VI secretion-like system of Francisella tularensis.

Authors:  Jeanette E Bröms; Moa Lavander; Anders Sjöstedt
Journal:  J Bacteriol       Date:  2009-02-06       Impact factor: 3.490

8.  Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Authors:  Karsten R O Hazlett; Seth D Caldon; Debbie G McArthur; Kerry A Cirillo; Girish S Kirimanjeswara; Micheal L Magguilli; Meenakshi Malik; Aaloki Shah; Scott Broderick; Igor Golovliov; Dennis W Metzger; Krishna Rajan; Timothy J Sellati; Daniel J Loegering
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

9.  Innate immune recognition of francisella tularensis: activation of type-I interferons and the inflammasome.

Authors:  Jonathan Wiley Jones; Petr Broz; Denise M Monack
Journal:  Front Microbiol       Date:  2011-02-03       Impact factor: 5.640

10.  The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection.

Authors:  Marie Lindgren; Jeanette E Bröms; Lena Meyer; Igor Golovliov; Anders Sjöstedt
Journal:  BMC Microbiol       Date:  2013-01-29       Impact factor: 3.605

View more
  15 in total

1.  Microinjection of Francisella tularensis and Listeria monocytogenes reveals the importance of bacterial and host factors for successful replication.

Authors:  Lena Meyer; Jeanette E Bröms; Xijia Liu; Martin E Rottenberg; Anders Sjöstedt
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

2.  Identification of mechanisms for attenuation of the FSC043 mutant of Francisella tularensis SCHU S4.

Authors:  Marie Lindgren; Linda Tancred; Igor Golovliov; Wayne Conlan; Susan M Twine; Anders Sjöstedt
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

3.  IglE is an outer membrane-associated lipoprotein essential for intracellular survival and murine virulence of type A Francisella tularensis.

Authors:  Gregory T Robertson; Robert Child; Christine Ingle; Jean Celli; Michael V Norgard
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

4.  Macrophage cell death upon intracellular bacterial infection.

Authors:  Xin-He Lai; Yunsheng Xu; Xiao-Ming Chen; Yi Ren
Journal:  Macrophage (Houst)       Date:  2015-04-26

5.  A method for functional trans-complementation of intracellular Francisella tularensis.

Authors:  Shaun Steele; Sharon Taft-Benz; Thomas Kawula
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 6.  Bacterial programming of host responses: coordination between type I interferon and cell death.

Authors:  Miqdad O Dhariwala; Deborah M Anderson
Journal:  Front Microbiol       Date:  2014-10-28       Impact factor: 5.640

7.  Francisella novicida pathogenicity island encoded proteins were secreted during infection of macrophage-like cells.

Authors:  Rebekah F Hare; Karsten Hueffer
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

8.  An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia.

Authors:  Sivakumar Periasamy; Dorina Avram; Amanda McCabe; Katherine C MacNamara; Timothy J Sellati; Jonathan A Harton
Journal:  PLoS Pathog       Date:  2016-03-25       Impact factor: 6.823

9.  A mutagenesis-based approach identifies amino acids in the N-terminal part of Francisella tularensis IglE that critically control Type VI system-mediated secretion.

Authors:  Jeanette E Bröms; Lena Meyer; Anders Sjöstedt
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

10.  Francisella tularensis IglG Belongs to a Novel Family of PAAR-Like T6SS Proteins and Harbors a Unique N-terminal Extension Required for Virulence.

Authors:  Mélanie Rigard; Jeanette E Bröms; Amandine Mosnier; Maggy Hologne; Amandine Martin; Lena Lindgren; Claire Punginelli; Claire Lays; Olivier Walker; Alain Charbit; Philippe Telouk; Wayne Conlan; Laurent Terradot; Anders Sjöstedt; Thomas Henry
Journal:  PLoS Pathog       Date:  2016-09-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.